Avalyn Raises $100m Series D To Advance Inhaled Pulmonary Fibrosis Candidates

 
• By Joseph Haas
  
Screen display representing venture capital investment
Avalyn raises a $100 series D round to fund development of three lead candidates • Source: Shutterstock

More from Financing

More from Business